Pinsent Masons appoints prominent Life Sciences partner in London

02 Nov 2021 | 03:00 pm | 1 min. read

Multinational law firm Pinsent Masons has recruited partner Dr Gareth Morgan to its European Life Sciences team, further strengthening its technology, science and industry (TSI) sector capabilities.

Gareth, who joins from CMS, is a market-leading pharma patent and medicines regulatory specialist, with significant experience in all areas of contentious and non-contentious intellectual property (IP) law. He has acted in many landmark UK IP trials concerning patent entitlement, pharmaceutical and biotechnology patent validity and infringement, SPCs and the interpretation of IP licences.

Joining the firm’s London office, he brings with him a team of five lawyers who will all work closely with partner Catherine Drew to expand the firm’s medicine regulatory litigation offering.

With a PhD in molecular biology, Gareth is passionate about the life sciences sector and joins a full-service team where many hold relevant scientific qualifications and degrees, including in genetics, medicinal chemistry, human biology, and biochemistry.

Head of IP & Life Sciences Clare Tunstall said:

"The needs of our life sciences clients are continuously evolving, and we need to ensure that we can support them across all business-critical areas. The appointment of Gareth will significantly bolster our ability to service our international client base, particularly in respect of medicine regulatory and patent litigation work where we are seeing a growing demand across our European business".

Head of technology, science & industry Florian von Baum added:

"Gareth’s reputation precedes him; he is a market leading international practitioner with deep sector knowledge and will add invaluable strength to our team. His appointment bolsters key proficiencies across our multinational team.”

Gareth’s hire follows the recent appointment of life sciences partners Gina Bicknell in London and Machteld Hiemstra in Amsterdam.

Key Contacts

Clare Tunstall

Clare Tunstall

Partner, Head of IP & Life sciences

View Profile

Latest press releases

Show me all press releases

Pinsent Masons appoints Pamela McDonald as new head of its Doha office

Multinational law firm Pinsent Masons has named international arbitration partner Pamela McDonald as the new head of its Doha office.

Multiple wins for Pinsent Masons at China Business Law Awards 2022

Multinational law firm Pinsent Masons has won in seven categories at China Business Law Journal's annual awards.

Pinsent Masons advises Ørsted on its entry into the Spanish renewables market

Multinational law firm Pinsent Masons has advised Ørsted on its first four renewables’ partnerships in Spain.

People who viewed this press release also viewed

Show me all press releases

Multiple wins for Pinsent Masons at China Business Law Awards 2022

Multinational law firm Pinsent Masons has won in seven categories at China Business Law Journal's annual awards.

Pinsent Masons Advises Accord Healthcare in Exclusive Licence Agreement with Myovant Sciences to Commercialise ORGOVYX® for Advanced Hormone-Sensitive Prostate Cancer in Europe

Pinsent Masons represented Accord Healthcare Ltd in an exclusive license agreement with Myovant Sciences to commercialise relugolix, Myovant’s advanced hormone-sensitive prostate cancer treatment, under the trade name ORGOVYX® in the European Economic Area, United Kingdom, Switzerland and Turkey.

Pinsent Masons advises on landmark financing of FINN

Multinational law firm Pinsent Masons has advised French investment company Korelya Capital on the EUR 100+ million financing of car subscription start-up FINN.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts